Log on / register
Feedback | Support | My details
Nanoparticles - known and unknown health risks.
Hoet PH, Brüske-Hohlfeld I, Salata OV
J Nanobiotechnology 2004 Dec 8, 2:12
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Real time in vitro studies of doxorubicin release from PHEMA nanoparticles
Chouhan R, Bajpai AK
Journal of Nanobiotechnology 2009, 7:5 (20 October 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Editorial    
Nanobiotechnology today: focus on nanoparticles
Soloviev M
Journal of Nanobiotechnology 2007, 5:11 (30 December 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [1 comment]
3.


Research    
An outbreak of cardiovascular syndromes requiring urgent medical treatment and its association with environmental factors: an ecological study
Turner RM, Muscatello DJ, Zheng W, Willmore A, Arendts G
Environmental Health 2007, 6:37 (25 November 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
4.


Research    
Three-dimensional reconstruction of cell nuclei, internalized quantum dots and sites of lipid peroxidation
Funnell WRJ, Maysinger D
Journal of Nanobiotechnology 2006, 4:10 (20 October 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [1 comment]

This article is also cited by a further 5 articles in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.